Singapore markets close in 45 minutes

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
36.62+0.07 (+0.19%)
At close: 1:00PM EST
36.62 0.00 (0.00%)
After hours: 01:33PM EST
Full screen
Trade prices are not sourced from all markets
Previous close36.55
Bid0.00 x 900
Ask0.00 x 1000
Day's range36.20 - 39.21
52-week range16.55 - 42.01
Avg. volume755,449
Market cap2.376B
Beta (5Y monthly)1.57
PE ratio (TTM)N/A
EPS (TTM)-0.24
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est39.38
  • Motley Fool

    Codexis Inc (CDXS) Q3 2021 Earnings Call Transcript

    With me today are John Nicols, Codexis' President and Chief Executive Officer; and Ross Taylor, Codexis' Chief Financial Officer. During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our guidance for 2021 total revenues, our updated guidance on product revenues and gross margin on product revenues, and our expectations regarding sales of one of our proprietary enzymes to Pfizer for the manufacture of their late clinical state COVID-19 antiviral therapeutic candidate.

  • Zacks

    Codexis (CDXS) Q3 Earnings and Revenues Beat Estimates

    Codexis (CDXS) delivered earnings and revenue surprises of 133.33% and 27.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Will Codexis (CDXS) Report Negative Earnings Next Week? What You Should Know

    Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.